The global infection control market at a CAGR of over 4% during the forecast period
NEW YORK, Dec. 4, 2019 /PRNewswire/ --
Global Infection Control Market: About this market
This infection control market analysis considers sales from both therapeutic and non-therapeutic types. Our study also finds the sales of infection control in Asia, Europe, North America, and ROW. In 2019, the therapeutic segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as anti-infectives, such as antibiotics, anti-fungal drugs, and anti-viral drugs, which are used for the prevention and treatment of various infectious diseases will play a significant role in the therapeutic segment to maintain its market position. Also, our global infection control market report looks at factors such as strong incidence of HAIs, increasing number of surgical procedures worldwide, and growing geriatric population. However, concerns regarding the safety of reprocessed instruments, non-compliance toward anti-infective therapy, and complexities involved in storage and transportation of infection control therapeutics may hamper the growth of the infection control industry over the forecast period.
Read the full report: https://www.reportlinker.com/p05829111/?utm_source=PRN
Global Infection Control Market: Overview
Growing geriatric population
The geriatric population is highly susceptible to infectious diseases. The incidence depends on the site of infection and location of the patient, whether a hospital, nursing home or community. Patients residing in nursing homes are mostly affected by pressure ulcer infections, urinary tract infection, and pneumonia. In addition, the chances of acquiring nosocomial infections are high among hospitalized elderly patients. Thus, the growth in the geriatric population will lead to the expansion of the global infection control market at a CAGR of over 4% during the forecast period.
Technological advances in sterilizing equipment
The global infection control market is currently witnessing an increasing interest of vendors to develop effective measures as infection control solutions. Vendors are increasingly exhibiting interest in developing effective measures as infection control solutions. Ultraviolet germicidal irradiation inactivates the pathogen by targeting their nucleic acids. The UV radiation is effective against all forms of pathogens, including bacteria, viruses, and fungi, and it has found widespread use in disinfecting surfaces, water, and air. The infection control systems that are based on these technologies, when used with appropriate care and protocols, can help reduce the incidences of HAIs and the health burden and economic costs associated with them. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global infection control market is moderately fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infection control manufacturers, that include 3M Co., Astellas Pharma Inc., Cantel Medical Corp., Ecolab Inc., Getinge AB, GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Pfizer Inc., and Sanofi.
Also, the infection control market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Read the full report: https://www.reportlinker.com/p05829111/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article